MB "Nanopharma" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 0 |
| - |
| -167 |
| -167 |
| - |
| - |
| - |
| 4,417 |
| 3,737 |
| 0 |
| 8,154 |
| 2023 |
|---|
| 0 |
| - |
| -356 |
| -356 |
| - |
| - |
| - |
| 4,061 |
| 4,521 |
| 0 |
| 8,582 |
| 2024 |
|---|
| 0 |
| - |
| -83 |
| -83 |
| - |
| - |
| - |
| 3,978 |
| 4,521 |
| 0 |
| 8,499 |
Register and
explore Okredo dataRegister and
explore Okredo data2024
Turnover (€)
0 €
- *
Sales per employee (€)
-Profit before tax (€)
-83 €
77 % *
Net Profit (€)
-83 €77 % *
Profit per employee (€)
-Total profitability (%)
-Net profitability (%)
-Equity (€)
3,978 €
-2 % *
Amounts Payable And Liabilities (€)
4,521 €0 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
8,499 €
-1 % *